SAN CLEMENTE, Calif. (AP) _ Glaukos Corp. (GKOS) on Tuesday reported a loss of $21.9 million in its fourth quarter.On a per-share basis, the San Clemente, California-based company said it had a loss of 47 cents. Losses, adjusted for non-recurring costs, were 31 cents per share.The results surpassed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 37 cents per share.The glaucoma treatments developer posted revenue of $73.2 million in the period, also topping Street forecasts. Six analysts surveyed by Zacks expected $67.3 million.For the year, the company reported that its loss narrowed to $49.6 million, or $1.07 per share. Revenue was reported as $294 million.Glaukos expects full-year revenue in the range of $265 million to $275 million._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GKOS at https://www.zacks.com/ap/GKOS